πŸ‡ΊπŸ‡Έ FDA
Patent

US 9186411

Pharmaceutical composition

granted A61KA61K31/4427A61K47/02

Quick answer

US patent 9186411 (Pharmaceutical composition) held by Takeda Pharmaceutical Company Limited expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/4427, A61K47/02, A61K47/10, A61K47/12